プロバイオティクス成分の世界市場予測（～2023年）...市場調査レポートについてご紹介

TABLE OF CONTENTS

1 INTRODUCTION 16
1.1 OBJECTIVES OF THE STUDY 16
1.2 MARKET DEFINITION 16
1.3 STUDY SCOPE 17
1.4 PERIODIZATION CONSIDERED 18
1.5 CURRENCY CONSIDERED 18
1.6 STAKEHOLDERS 19
2 RESEARCH METHODOLOGY 20
2.1 RESEARCH DATA 20
2.1.1 SECONDARY DATA 21
2.1.2 PRIMARY DATA 21
2.1.2.1 Key industry insights 21
2.1.2.2 Breakdown of primary interviews 22
2.2 MARKET SIZE ESTIMATION 22
2.3 DATA TRIANGULATION 25
2.4 RESEARCH ASSUMPTIONS 26
2.5 LIMITATIONS 26
3 EXECUTIVE SUMMARY 27
4 PREMIUM INSIGHTS 32
4.1 OPPORTUNITIES IN THE PROBIOTIC INGREDIENTS MARKET 32
4.2 PROBIOTIC INGREDIENTS MARKET, BY SOURCE 33
4.3 ASIA PACIFIC: PROBIOTIC INGREDIENTS MARKET, BY APPLICATION 34
4.4 PROBIOTIC INGREDIENTS MARKET, BY END USER AND REGION 35
4.5 PROBIOTIC INGREDIENTS MARKET GROWTH, BY KEY COUNTRY 35
5 MARKET OVERVIEW 36
5.1 INTRODUCTION 36
5.2 MARKET DYNAMICS 37
5.2.1 DRIVERS 38
5.2.1.1 Health benefits associated with probiotic-fortified foods 38
5.2.1.2 Increasing popularity of probiotic dietary supplements 38
5.2.1.3 Participation of international bodies in the R&D of probiotics 39
5.2.1.4 Increasing global demand for superior-quality feed products 40
5.2.2 RESTRAINTS 41
5.2.2.1 International quality standards and regulations for probiotic products 41
 
5.2.3 OPPORTUNITIES 41
5.2.3.1 EU ban on antibiotic growth promoters in feed 41
5.2.3.2 Increasing demand for probiotics in developed economies 42
5.2.3.3 Promoting probiotic health benefits among livestock farmers 42
5.2.4 CHALLENGES 42
5.2.4.1 Complexities in integrating probiotics in functional food 42
5.2.4.2 Significant operating cost 42
5.2.4.3 Proving the efficacy of probiotic strains 43
6 REGULATORY FRAMEWORK AND PATENTS 44
6.1 INTRODUCTION 44
6.2 NORTH AMERICA: REGULATORY ENVIRONMENT ANALYSIS 44
6.2.1 US 45
6.2.2 CANADA 46
6.3 EUROPE: REGULATORY ENVIRONMENT ANALYSIS 46
6.4 ASIA PACIFIC: REGULATORY ENVIRONMENT ANALYSIS 47
6.4.1 JAPAN 47
6.4.2 INDIA 47
6.5 SOUTH AMERICA: REGULATORY ENVIRONMENT ANALYSIS 48
6.5.1 BRAZIL 48
6.6 PATENT ANALYSIS 48
7 PROBIOTIC INGREDIENTS MARKET, BY APPLICATION 50
7.1 INTRODUCTION 51
7.2 FUNCTIONAL FOODS & BEVERAGES 52
7.2.1 DAIRY PRODUCTS 53
7.2.1.1 Yogurt 53
7.2.1.2 Cheese 54
7.2.1.3 Other Dairy Products 54
7.2.2 NON-DAIRY PRODUCTS 54
7.2.2.1 Vegetable-based probiotic products 54
7.2.2.2 Fruit-based probiotic products 54
7.2.2.3 Meat-based probiotic products 54
7.3 PHARMACEUTICALS 57
7.3.1 DIETARY SUPPLEMENTS 57
7.3.1.1 Tablets 57
7.3.1.2 Probiotic Drinks 57
7.3.1.3 Powders 58
7.3.1.4 Capsules 58
7.4 ANIMAL NUTRITION 60
7.5 OTHERS 63
8 PROBIOTIC INGREDIENTS MARKET, BY SOURCE 66
8.1 INTRODUCTION 67
8.2 BACTERIA 68
8.2.1 LACTOBACILLUS 69
8.2.2 BIFIDOBACTERIUM 69
8.2.3 STREPTOCOCCUS AND ENTEROCOCCUS 69
8.3 YEAST 70
8.3.1 SACCHAROMYCES CEREVISIAE 71
8.3.2 SACCHAROMYCES BOULARDI 71
8.3.3 E. COLI 71
9 PROBIOTICS INGREDIENTS MARKET, BY FORM 72
9.1 INTRODUCTION 73
9.2 DRY 74
9.2.1 DRY FORM HOLDS THE LARGEST MARKET SHARE DUE TO ITS STABILITY AND LONGER SHELF-LIFE 74
9.3 LIQUID 75
9.3.1 LIQUID FORM HAS A FASTER GROWING MARKET DUE TO BEING RELATIVELY CHEAPER THAN DRY FORM. 75
10 PROBIOTICS INGREDIENTS MARKET, BY END USER 76
10.1 INTRODUCTION 77
10.2 HUMAN 78
10.2.1 INTESTINAL DISORDERS 78
10.2.2 LACTOSE INTOLERANCE 78
10.2.3 INFLAMMATORY BOWEL DISORDERS 78
10.2.4 CARDIOVASCULAR DISEASES 79
10.2.5 RESPIRATORY INFECTIONS 79
10.2.6 OBESITY 79
10.2.7 UROGENITAL INFECTIONS 79
10.2.8 TYPE-2 DIABETES 79
10.2.9 CANCER 79
10.3 ANIMAL 80
11 PROBIOTIC INGREDIENTS MARKET, BY REGION 83
11.1 INTRODUCTION 84
11.2 NORTH AMERICA 86
11.2.1 US 90
11.2.1.1 US accounted for the largest share in North American market due to higher adoption of technologies 90
11.2.2 CANADA 91
11.2.2.1 Canada has huge potential for probiotic ingredients due to increasing investments by big players 91
11.2.3 MEXICO 92
11.2.3.1 Increasing demand from the pharmaceuticals industry is expected to drive the market for probiotic strains in Mexico 92
11.3 EUROPE 93
11.3.1 UK 95
11.3.1.1 Higher pace of technological advancements is driving the market for probiotic ingredients in the country 95
11.3.2 GERMANY 96
11.3.2.1 Ban on usage of antibiotics by the EU in the poultry industry is proving to be an opportunity for probiotics in the country 96
11.3.3 ITALY 97
11.3.3.1 Consumer awareness about health benefits of probiotics is driving the market in the country 97
11.3.4 SPAIN 98
11.3.4.1 Increasing investment in probiotics by big players in the country is driving the market 98
11.3.5 RUSSIA 99
11.3.5.1 Increasing demand for fermented dairy products in the country is driving the market for probiotic ingredients 99
11.3.6 REST OF EUROPE 100
11.3.6.1 Consumer acceptance for probiotic products driving the market for probiotic ingredient 100
11.4 ASIA PACIFIC 101
11.4.1 CHINA 105
11.4.1.1 The market in China is growing due to the increasing application of probiotics in infant formula business 105
11.4.2 JAPAN 106
11.4.2.1 Increase in health care costs is one of the driving forces for the probiotic ingredients market 106
11.4.3 AUSTRALIA & NEW ZEALAND 107
11.4.3.1 Technological advancements in probiotics is driving the market in the countries 107
11.4.4 INDIA 108
11.4.4.1 India has huge potential due to the increase in pharmaceutical companies investing in development of probiotic drugs 108
11.4.5 REST OF ASIA PACIFIC 109
11.4.5.1 Fermented dairy products have gained popularity in these countries 109
11.5 ROW 110
11.5.1 SOUTH AMERICA 112
11.5.1.1 The increased demand for good quality meat from consumers presents an immense opportunity for application of probiotic strains in animal feed 112
11.5.2 MIDDLE EAST & AFRICA 113
11.5.2.1 Functional foods & beverages has the largest market share in Middle East due to the application of inexpensive technology of fermentation in the manufacture of end products 113
12 COMPETITIVE LANDSCAPE 114
12.1 OVERVIEW 114
12.2 EXPANSIONS & INVESTMENTS 116
12.3 AGREEMENTS, COLLABORATIONS, AND JOINT VENTURES & PARTNERSHIPS 117
12.4 PRODUCT LAUNCHES 119
12.5 MERGERS & ACQUISITIONS 120
13 COMPANY PROFILES 121
(Business overview, Products offered, Recent Developments, SWOT analysis, MNM view)*
13.1 KERRY 121
13.2 DOWDUPONT 124
13.3 CHR. HANSEN 127
13.4 BIOGAIA 130
13.5 PROBI 133
13.6 GLAC BIOTECH 136
13.7 BIFODAN 138
13.8 LALLEMAND 141
13.9 UAS LABORATORIES 143
13.10 BIENA 145
*Details on Business overview, Products offered, Recent Developments, SWOT analysis, MNM view might not be captured in case of unlisted companies.
14 APPENDIX 147
14.1 DISCUSSION GUIDE 147
14.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 150
14.3 AVAILABLE CUSTOMIZATIONS 152
14.4 RELATED REPORTS 152
14.5 AUTHOR DETAILS 153